日本語中文

ABOUT HUAWEI HEALTH

       Established in 1992, Huawei Pharmaceutical Group is a joint venture affiliated to National Health Commission of the People’s Republic of China (the original Ministry of Health P. R. China). In the initial period of founding, it only guaranteed the pharmaceutical security of the Leading Cadre and various ministries and commissions. After over 2 decades of development, it has engaged in 4 major fields, including medicine sales, medical consulting, pharmaceutical consulting and new product technology development to urge the health undertaking of the Chinese people, medical and healthcare services and international exchanges, so as to strive for the great goal of Healthy China.

1992

Founded in 1992

29

After 29 years of development

4

4 business development sectors

Past leadership

1991-2000 Chairman, legal person
Cao Ronggui
Cao Ronggui,
Deputy Direct General of the Ministry of Health
2000-2006 Chairman, legal person
Xue Xiaolin
Xue Xiaolin,
Direct General
2006-2012 Chairman, legal person
Ma Aining
Ma Aining,
Direct General
2012-Present Chairman, legal person
Guan Qingwei

Guan Qingwei


Social relation:Member of the Chinese Peasants and Works Democratic Party

Social position: Member of the Chinese Neuromodulation Society (CNMS)

Member of the First Standing Committee of the Chinese International Exchange and Promotive Association for Medical and Health Care, Deputy Director of the Traditional Chinese Medicine Promotion Project of the National Comprehensive Hospital of Chinese Traditional Chinese Medicine Science and Technology Development Center

 

 

 


Company Mission
  • Become an integrator, innovator and sharer in the field of Chinese Massive Health and serve our customers in health wholeheartedly

Development history

1992
Registration of Beijing Huawei Industrial Corporation in 1992
2001
In 2001, the nature of the company changed from collective ownership to ownership by the whole people
2011
New business scope in 2011: Sales of chemical APIs, western medicine preparations, biological preparations, Chinese patent medicines and medical devices.
2012
In 2012, Guan Qingwei served as chairman
2015
In 2015, the registered capital increased to build strength for future development
2016
In 2016, the International Department was established to carry out cooperation and exchanges in Japan's overseas markets.
2017
In 2017, the promotion project of traditional Chinese medicine in national general hospitals was launched
2018
The first Sino Japanese medical and health exchange conference will be held in 2018
2019
In 2019, the company changed into a group
2020
The second China Japan medical and health exchange conference will be held in 2020
2021
In 2021, the three medical mutual health fund and drug comprehensive evaluation center were established
2022

Organizing the 2022 (third) China Japan medical and Health Exchange Conference


Mobile phone

Wechat

ADD:2812/2815/2816/2817, Nanyin building, No. 2, East Third Ring North Road, Chaoyang District, Beijing
Tel:+86-10-61006202/61006203
Fax:+86-10-61006309
URL:www.exjgv.cn 

Copyright(C)2022,Huawei Pharmaceutical Group All Rights Reserved.
 Supported by Toocle 31fabu Copyright Notice

可以免费观看的黄色网站,国产XXXX色视频在线观看免费,91色在线,18禁无码国内精品久久综合88